WO1998001107A1 - Skin moisturizing and protective cosmetic compositions - Google Patents
Skin moisturizing and protective cosmetic compositions Download PDFInfo
- Publication number
- WO1998001107A1 WO1998001107A1 PCT/BR1997/000025 BR9700025W WO9801107A1 WO 1998001107 A1 WO1998001107 A1 WO 1998001107A1 BR 9700025 W BR9700025 W BR 9700025W WO 9801107 A1 WO9801107 A1 WO 9801107A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- usual
- titanium dioxide
- moisturizing
- agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 25
- 239000002537 cosmetic Substances 0.000 title claims abstract description 17
- 230000001681 protective effect Effects 0.000 title abstract description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 50
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 26
- 230000005855 radiation Effects 0.000 claims abstract description 26
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 25
- 230000002225 anti-radical effect Effects 0.000 claims abstract description 20
- 239000000126 substance Substances 0.000 claims abstract description 16
- 239000010445 mica Substances 0.000 claims abstract description 12
- 229910052618 mica group Inorganic materials 0.000 claims abstract description 12
- 239000000654 additive Substances 0.000 claims abstract description 11
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 11
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 11
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 claims abstract 7
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims abstract 7
- 229960001173 oxybenzone Drugs 0.000 claims abstract 7
- 230000000295 complement effect Effects 0.000 claims abstract 3
- 230000004224 protection Effects 0.000 claims description 14
- -1 rhamnetol Chemical compound 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 239000003974 emollient agent Substances 0.000 claims description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000003352 sequestering agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 241001474374 Blennius Species 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- IMPKVMRTXBRHRB-MBMOQRBOSA-N (+)-quercitol Chemical compound O[C@@H]1C[C@@H](O)[C@H](O)C(O)[C@H]1O IMPKVMRTXBRHRB-MBMOQRBOSA-N 0.000 claims description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 2
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- 150000001398 aluminium Chemical class 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- 229940093797 bioflavonoids Drugs 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 claims description 2
- 239000010941 cobalt Substances 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 claims description 2
- 229960001083 diazolidinylurea Drugs 0.000 claims description 2
- 229960000735 docosanol Drugs 0.000 claims description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 claims description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 claims description 2
- 229940093496 esculin Drugs 0.000 claims description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 2
- 229940099367 lanolin alcohols Drugs 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000000391 magnesium silicate Substances 0.000 claims description 2
- 235000012243 magnesium silicates Nutrition 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 claims description 2
- 229940096792 quaternium-15 Drugs 0.000 claims description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000005493 rutin Nutrition 0.000 claims description 2
- 229960004555 rutoside Drugs 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 235000020778 linoleic acid Nutrition 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 1
- 235000021313 oleic acid Nutrition 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims 1
- 150000003548 thiazolidines Chemical class 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 16
- 230000003711 photoprotective effect Effects 0.000 description 12
- 230000009471 action Effects 0.000 description 10
- 230000006378 damage Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 4
- 239000012965 benzophenone Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000036572 transepidermal water loss Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010068388 Actinic elastosis Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 230000037338 UVA radiation Effects 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 238000006552 photochemical reaction Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 231100000589 photocarcinogenesis Toxicity 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 125000003259 prostaglandin group Chemical group 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000006833 reintegration Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000008354 tissue degradation Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention refers to skin moisturizing and protective cosmetic compositions against ultraviolet and infrared radiation, which contain natural origin melanin pigment as free radicals capturer.
- UV ultraviolet radiation
- UV rays are responsible for collagen fibers destruction and for abnormal elastic fibers production, besides promoting alterations on the dermal microvascularization.
- the skin suffers degeneration in its structure and abnormalities in its normal pigmentation process.
- the free radicals formation has an important role in the so called photoaging, due to the attack upon the cutaneous tissue structural molecules as much as due to their self-defense implication, the antioxidant mechanisms.
- the new solar protection compositions comprise filters with a much wider protection spectrum, considering also infrared (IR) radiation, whose main biological manifestation is felt in form of heat. Recent studies showed the high damaging potential that this solar spectrum range can cause in synergy with UV radiation.
- IR infrared
- the natural origin melanin is also included in the photoprotectives. This compound, skin's normal defense essential substance, is responsible for sunlight absorption and reflection mechanisms, and is capable of promoting free radicals stabilization, which are generated by the incident radiation.
- the flavonoids contained in a vegetable extract of considerable anti- inflammatory and antiradicals actions.
- the solar spectrum reaching earth's surface is formed by visible light (400 to 700 nm), infrared radiation (700 to 3000 nm) and, in last instance, microwaves and radio waves
- visible light 400 to 700 nm
- infrared radiation 700 to 3000 nm
- microwaves and radio waves The radiations exhibiting the longer wave lengths are the ones with deeper cutis penetration, being almost able of crossing it
- the biological response against IR radiation (which promotes a molecules vibration) is specifically given as a temperature increase For wave lengths longer than 800 nm, occurs also a photochemical reaction similar to UV
- IR rays increase the damages that would be caused only by UV rays formation of elastic fibers much different from those resulting in actinic elastosis (they are thinner, being similar to feathers), influence over the dermal collagen quantity with a mucopolysacchandes concentration increase (proportional to irradiation period) and damages in the cellular DNA structure and its restoring mechanism (IR exclusive action), what contributes to an oncogenic action
- the acute IR radiation exposition promotes epidermis pidic bilayer thickness reduction, erythema with blood vessels dilatation, mastocytes granulation (cells of the organism defense system) and free arachidonic acid and prostaglandines concentration increase, these are mediator agents of the radiation induced inflammatory response
- the chronic exposition can cause solar elastosis and lead to cutaneous aging due to actinic action
- IR and UV radiations effects are difficult of being separately considered they exhibit synergetic actuation on photoagmg and photocarcinogenesis
- the knowledge of the damaging effects caused by this non-ionizing radiation obliges technological development in direction to the manufacturing of products also conside ⁇ ng this IR radiation
- the active component selected to exert IR protective function is a mineral pigment, capable of reflecting this radiation Basically, it is a titanium dioxide micronized particle, coated with mica (10 to 60 ⁇ m diameter), commercially known as Timiron Super Red ® (Merck).
- the reflective agent is capable of producing a 5 to 7°C temperature reduction on the cutaneous surface.
- the melanins are organic polymers exhibiting several conjugated double bindings, so that they perform light absorption in the UV, visible light and IR ranges. Specifically, these wide spectrum pigments perform an uniform UVA radiation absorption, exerting an important role in the direct photoprotection related to this spectrum range.
- the melanin added to the photoprotectives contained in the new solar composition is a natural product obtained through the refinement of cephalopods tincture: Sepia Melanilna ® (Melco). It is a non-toxic and hypoallergenic product. It is a photoprotector agent and free radicals capturer, produced by sunlight. Its main actions are:
- Antioxidant protects the cells against oxygen metabolites, inhibiting the lipidic peroxidation and exerting an important protective role against oxidative protean damage. In a 0,25% concentration, is capable of inhibiting 71% of the substrate oxidation process. For a brief comparison, 0,10% of vitamin E acetate (considered one of the best antioxidizing agents) reduces the oxidation process in 89%.
- Free radicals capturer melanin is considered a stable free radical; consequently exhibits an electrons exchange ability. This property enables it to "neutralize" free radicals which can cause cell damage.
- Photoprotection actuates against erythema, actinic aging and skin cancer. Acts together with other filters, helping in the SPF value increase.
- UVB filters + melanin are excellent protectives against UVA and UVB radiation and lipidic peroxidation, promoting a 15% reduction in the damages caused by UVA rays and a 96,58% reduction in the damages caused by UVB rays.
- the bioflavonoids (rutin, quercitol, rhamnetol, esculin) are protection factors derived from vitamin P, which are concerned in the capillary permeability process. They exhibit properties against skin aging, inhibiting the action of enzymes responsible for conjunctive tissue degradation (collagenase, elastosis, hyaluronidase). They stimulate the cells mitotic potential and exhibit antiradicals, scaring, repairing and re-balancing properties for the skin damaged by the sun.
- the solar exposition promotes a skin tissue temperature increase, resulting in perspiration, leading to water and mineral loss.
- seaweeds extract As hydrophilic agents for the reposition of the lost hydration, minerals contained in seaweeds extract were chosen: selenium, zinc, chrome, calcium, magnesium, silicon, fluorine, nickel and cobalt. These elements, also known as oligoelements, participate in the cells normal growth, in the synthesis of proteins precursors and codifiers (RNA and DNA), in the synthesis (zinc and silicon) and transformation (copper) of tropocollagen in collagen, in the transformation of keratin precursor in keratin in the corneal layer and in the electrons transportation in the respiratory chain.
- the seaweeds extract active components supply water and electrolytes to the conjunctive tissue, conferring skin turgidity and firmness, increasing skin tension and improving its elasticity. They also react with the corneal layer amino groups, forming protective pellicles and reducing the transepidermal water loss.
- the present invention refers, in particular, to anti-solar emulsions, for skin protection against aggressions caused by UVB, UVA and IR radiation. They have moisturizing function and their differential is based on the antiradicals action.
- the main active component is melanin, of natural origin. They are water-resistant products.
- compositions are manufactured through usual processing techniques, exception made to the powders dispersion, which requires special attention to avoid posterior agglomeration.
- the oily phase or, better, the non-aqueous phase shall be previously heated at 80°C and, together with titanium dioxide, be submitted to a high efficiency homogenizer, in order to guarantee total pigment dispersion.
- the coated particle shall not be submitted to trituration.
- the already dispersed oily phase should be added to the aqueous phase, so that it is possible to proceed to emulsification.
- the product should be cooled down at 45°C for the IR filter and melanin incorporation, in order to guarantee these active components action.
- the process termination is done through the addition of the remaining formulation ingredients.
- the invention provides fluid emulsions, lightly pigmented (brownish), not oily, not fatty and of easy spreading, in order to guarantee the uniformity of the protective film applied onto the skin.
- This photoprotectives line contains chemical filters, that protect the skin against the damages caused by UVB and UVA radiation (absorption).
- the physical filters with a wider spectrum, are UVB, UVA and IR radiation reflectors.
- the natural melanin in synergy with vitamin E, confers the product free radicals capturing action, neutralizing unstable molecules and avoiding the formation of new ones (chain reaction).
- the moisturizing action occurs through oligoelements reposition (micronutrients), which are lost together with the transepidermal water loss (TEWL) when the skin is exposed to the sun (excessive drying).
- oligoelements reposition micronutrients
- TEWL transepidermal water loss
- compositions contain, besides their active components, additional materials or additives. These are added to guarantee formulation physicochemical and microbiological stability, as also a pleasant sensorial when the product is applied to the skin.
- the additional materials constituting the formulation vehicle include sequestering, antioxidant and preservative agents, emollients, thickeners/ neutralizers and emulgators, already known by themselves, that can be solid or liquid. Examples of each of these components, that can be used associated or separately, and their usage concentration, include:
- Sequestering agent 0,05 to 0,50%
- BHT butyl hydroxytoluene
- BHA butyl hydroxyanisole
- emollients we can name isopropyl isostearate, isobutyl palmitate, isocetyl stearate, octyl palmitate, isopropyl laurate, cetyl lactate, isopropyl linoleate, palmitic acid, oleic alcohol, octadecanol, behenyl alcohol, cetyl palmitate, octyl isostearate, isopropyl stearate, alkyl benzoate, mineral oil, lanolin alcohols and derivatives, waxes and vegetable oils, and silicone and their derivatives.
- sorbitan As emulgators, we can name sorbitan, glycerol, waxes and phosphated fatty amines derivatives, acrylic polymers, polyoxiethylenes, polyethylene glycols derivatives, with or without neutralization.
- thickeners we can name carboxyvinyl polymers, gums, starches, modified aluminium and magnesium silicates, alkylaryl ammonium, esmectitas, cellulose derivatives, hydrated aluminium silicates.
- EDTA ethylenediamine tetraacetic acid
- ethydronic acid ethydronic acid
- deferrioxamine lactoferrine
- SPF 4 chemical filter: octyl metoxycinnamate2, 000-4, 000% chemical filter: butyl metoxy dibenzoyl methane0,200-1,000% chemical filter: benzophenone 30,500-1 ,000% physical filter: coated titanium dioxide 0,000-1 ,000% physical filter IV: titanium dioxide and mica 0,500-1,000% antiradicals agent: natural melanin0,005-1 ,000% antiradicals/moisturizing agent:0, 100-2,000% moisturizing agent: oligoelementsO, 500-5, 000% SPF 8: chemical filter: octyl metoxycinnamate3, 000-6,000% chemical filter: butyl metoxy dibenzoyl methanel , 000-2,000% chemical filter: benzophenone 31,000-3,000% physical filter: coated titanium dioxide 1 ,000
- antiradicals agent natural melanin0,005-1,000%
- moisturizing agent oligoelements0,500-5,000% Summing up the referred active components, we obtain the following minimal and maximal values for the four above mentioned types, being: 3,805 to 16,000% for SPF 4 7,105 to 22,000% for SPF 8 11 ,605 to 28,000% for SPF 15 14,605 to 34,000% for SPF 30
- the SPF 4 type will be completed with these usual additives, whose conjoint ratio will vary between 96,195% to 84,000%, by weight, in order to complete global composition's 100%.
- the SPF 8 type will be completed with 92,895% to 78,000%, by weight, of these additives.
- SPF 15 type composition 88,395% to 72,000%, by weight, of the referred formulation additives will be added.
- SPF 30 type composition 85,395% to 66,000%, by weight, will be added.
- the first step is the preparation of two phases: an oily phase, in other words, not exactly aqueous, and an aqueous phase.
- the oily phase non-aqueous, is prepared first, with the addition of surfactant agent, if suitable, and titanium dioxide pigment (without coating), including heating and mechanical homogenization.
- the aqueous phase also heated at 80°C, and containing the completing ingredients, specially the emulsifying agent, is added to this first prepared oily phase.
- the solar protection compositions were submitted to usual dermatological tests, which include primary and accumulated dermal irritability, sensitization, phototoxicity and photoallergy. These tests, when exhibiting favorable results as in this present case, guarantee the products innocuousness and confer them the condition of "dermatologist tested”. The products were also submitted to the comedogenicity test, what confers the products the status of "not comedogenic”.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97935379A EP0859589A1 (en) | 1996-07-05 | 1997-07-04 | Skin moisturizing and protective cosmetic compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9602991A BR9602991A (en) | 1996-07-05 | 1996-07-05 | Skin moisturizing and protective cosmetic compositions against ultraviolet and infrared radiation |
BRPI9602991-9 | 1996-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998001107A1 true WO1998001107A1 (en) | 1998-01-15 |
Family
ID=4064594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR1997/000025 WO1998001107A1 (en) | 1996-07-05 | 1997-07-04 | Skin moisturizing and protective cosmetic compositions |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0859589A1 (en) |
AR (1) | AR007721A1 (en) |
BR (1) | BR9602991A (en) |
CA (1) | CA2231275A1 (en) |
CO (1) | CO5280067A1 (en) |
MX (1) | MX9801733A (en) |
WO (1) | WO1998001107A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0898955A2 (en) * | 1997-08-09 | 1999-03-03 | MERCK PATENT GmbH | Sunscreen agent showing ultra-spectral protection |
WO1999024000A3 (en) * | 1997-11-12 | 1999-07-29 | Merck Patent Gmbh | Light stable cosmetic formulation containing butylmethoxydibenzoylmethane |
WO1999062476A1 (en) * | 1998-06-04 | 1999-12-09 | Unilever Plc | Sunscreen cosmetic composition |
GB2352174A (en) * | 1999-07-22 | 2001-01-24 | Secr Defence | Barrier creams for the mitigation of heat burns |
US6333041B1 (en) | 1998-03-02 | 2001-12-25 | Children's Hospital Medical Center | Nontoxic vernix compositions and method of producing |
DE10050155A1 (en) * | 2000-10-11 | 2002-04-18 | Beiersdorf Ag | Stabilization of cosmetic or dermatological emulsions, hydrogels or oleogels useful eg as skin-care or make-up compositions is by addition of desferrioxamine |
US6562358B2 (en) | 1998-03-02 | 2003-05-13 | Children's Hospital Medical Center | Nontoxic vernix compositions and method of producing |
WO2003075876A1 (en) * | 2002-03-12 | 2003-09-18 | Ove Karlsson Konsult | New composition including a pigment assembly comprising a mica core |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US7959935B2 (en) | 2002-05-03 | 2011-06-14 | Children's Hospital Medical Center | Simulated vernix compositions for skin cleansing and other applications |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US8001926B2 (en) | 2002-11-07 | 2011-08-23 | Abbott Laboratories | System and method of loading and detecting beneficial agent on a prosthesis |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
WO2012107550A2 (en) | 2011-02-11 | 2012-08-16 | Laboratorios Cinfa, S.A. | Biotechnologically derived active in cosmetic compositions useful for protecting the skin from damages induced or produced by infrared-radiations |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
KR101511021B1 (en) | 2012-06-28 | 2015-04-10 | 동국대학교 산학협력단 | Composition for diagnosis of melanocyte cytotoxicity |
EP2600824A4 (en) * | 2010-06-29 | 2016-03-09 | Amorepacific Corp | Cosmetic composition for preventing skin aging |
EP2233127B1 (en) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2206282A (en) * | 1987-06-23 | 1989-01-05 | Neutrogena Corp | Topical composition for protecting against solar radiation |
EP0518773A1 (en) * | 1991-06-14 | 1992-12-16 | L'oreal | Cosmetic composition containing a blend of metallic oxids nanopigments and melanic pigments |
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
-
1996
- 1996-07-05 BR BR9602991A patent/BR9602991A/en unknown
-
1997
- 1997-07-03 AR ARP970102979A patent/AR007721A1/en unknown
- 1997-07-04 WO PCT/BR1997/000025 patent/WO1998001107A1/en not_active Application Discontinuation
- 1997-07-04 CO CO97037285A patent/CO5280067A1/en unknown
- 1997-07-04 CA CA 2231275 patent/CA2231275A1/en not_active Abandoned
- 1997-07-04 EP EP97935379A patent/EP0859589A1/en not_active Withdrawn
-
1998
- 1998-03-04 MX MX9801733A patent/MX9801733A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2206282A (en) * | 1987-06-23 | 1989-01-05 | Neutrogena Corp | Topical composition for protecting against solar radiation |
EP0518773A1 (en) * | 1991-06-14 | 1992-12-16 | L'oreal | Cosmetic composition containing a blend of metallic oxids nanopigments and melanic pigments |
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
EP0898955A3 (en) * | 1997-08-09 | 2001-11-21 | MERCK PATENT GmbH | Sunscreen agent showing ultra-spectral protection |
EP0898955A2 (en) * | 1997-08-09 | 1999-03-03 | MERCK PATENT GmbH | Sunscreen agent showing ultra-spectral protection |
WO1999024000A3 (en) * | 1997-11-12 | 1999-07-29 | Merck Patent Gmbh | Light stable cosmetic formulation containing butylmethoxydibenzoylmethane |
US6436374B1 (en) | 1997-11-12 | 2002-08-20 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Light-stable cosmetic formulation containing butylmethoxydibenzoylmethane |
US6333041B1 (en) | 1998-03-02 | 2001-12-25 | Children's Hospital Medical Center | Nontoxic vernix compositions and method of producing |
US6562358B2 (en) | 1998-03-02 | 2003-05-13 | Children's Hospital Medical Center | Nontoxic vernix compositions and method of producing |
US6846490B2 (en) | 1998-03-02 | 2005-01-25 | Children's Hospital Medical Center | Nontoxic vernix compositions and method of producing |
WO1999062476A1 (en) * | 1998-06-04 | 1999-12-09 | Unilever Plc | Sunscreen cosmetic composition |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US6309631B1 (en) | 1999-07-22 | 2001-10-30 | Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Barrier cream |
GB2352174A (en) * | 1999-07-22 | 2001-01-24 | Secr Defence | Barrier creams for the mitigation of heat burns |
GB2352174B (en) * | 1999-07-22 | 2004-06-23 | Secr Defence | Barrier cream |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
WO2001037847A3 (en) * | 1999-11-22 | 2002-01-17 | Childrens Hosp Medical Center | Nontoxic vernix compositions and method of producing |
DE10050155A1 (en) * | 2000-10-11 | 2002-04-18 | Beiersdorf Ag | Stabilization of cosmetic or dermatological emulsions, hydrogels or oleogels useful eg as skin-care or make-up compositions is by addition of desferrioxamine |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US7897144B2 (en) | 2001-02-28 | 2011-03-01 | Johnson & Johnson Comsumer Companies, Inc. | Compositions containing legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
WO2003075876A1 (en) * | 2002-03-12 | 2003-09-18 | Ove Karlsson Konsult | New composition including a pigment assembly comprising a mica core |
US7959935B2 (en) | 2002-05-03 | 2011-06-14 | Children's Hospital Medical Center | Simulated vernix compositions for skin cleansing and other applications |
US8001926B2 (en) | 2002-11-07 | 2011-08-23 | Abbott Laboratories | System and method of loading and detecting beneficial agent on a prosthesis |
EP2233127B1 (en) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP1591105B1 (en) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP2600824A4 (en) * | 2010-06-29 | 2016-03-09 | Amorepacific Corp | Cosmetic composition for preventing skin aging |
WO2012107550A2 (en) | 2011-02-11 | 2012-08-16 | Laboratorios Cinfa, S.A. | Biotechnologically derived active in cosmetic compositions useful for protecting the skin from damages induced or produced by infrared-radiations |
KR101511021B1 (en) | 2012-06-28 | 2015-04-10 | 동국대학교 산학협력단 | Composition for diagnosis of melanocyte cytotoxicity |
Also Published As
Publication number | Publication date |
---|---|
EP0859589A1 (en) | 1998-08-26 |
CO5280067A1 (en) | 2003-05-30 |
AR007721A1 (en) | 1999-11-10 |
BR9602991A (en) | 1998-04-28 |
CA2231275A1 (en) | 1998-01-15 |
MX9801733A (en) | 1998-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998001107A1 (en) | Skin moisturizing and protective cosmetic compositions | |
US4806344A (en) | Sun protectant composition and method | |
CH695085A5 (en) | Formulations for care of the skin after laser treatment and / or chemical peels, and use of formulations. | |
FR2751542A1 (en) | COMPOSITION FOR PROTECTING SKIN OR HAIR CONTAINING NANOPIGMENTS AND AN ELASTOMERIC SOLID ORGANOPOLYSILOXANE ASSOCIATED WITH A FATTY PHASE | |
CN115024994B (en) | High-safety sun-screening composition and preparation method and application thereof | |
LU86844A1 (en) | USE AS A COSMETIC PRODUCT OF A COPPER COMPLEX OF 3,5-DIISOPROPYL SALICYLIC ACID AND COSMETIC COMPOSITIONS FOR THE PROTECTION OF THE HUMAN SKIN AGAINST UV RADIATION CONTAINING THIS COMPOUND | |
DE69600871T3 (en) | Filtering composition for cosmetic or dermatological use containing a chelating agent for iron | |
JP3582936B2 (en) | External preparation for skin | |
US6165449A (en) | Methods and compositions for improving sun protection from sunscreen formulations | |
CA2181738A1 (en) | Cosmetic or dermatological filtering composition | |
CN117064781A (en) | Safe and mild sun-screening composition and application thereof | |
KR100684367B1 (en) | Cosmetic composition containing sunscreen polysilsesquioxane spherical particles | |
JP2716393B2 (en) | Compositions against skin spots and / or aging and methods of use thereof | |
EP2618892B1 (en) | High protection uva/uvb composition and topical cosmetic composition | |
EP0749750B1 (en) | Composition for whitening, antiageing and/or protection of the skin and uses thereof | |
JP3162513B2 (en) | UV protection cosmetics | |
JP2537444B2 (en) | UV protection and anti-wrinkle agent | |
JP2004519487A (en) | Pharmaceutical cosmetic composition for protecting skin from sun damage | |
JPS62120312A (en) | Skin beautifying cosmetic | |
BR102017014814B1 (en) | DYED SUNSCREEN COMPOSITIONS WITH OIL CONTROL | |
PL242752B1 (en) | Composition containing mangiferin, use of the composition, method of making the composition, and cosmetic product and base containing the composition | |
JP3582937B2 (en) | External preparation for skin | |
JPH0820524A (en) | Skin external preparation and tyrosinase activity inhibitor and humectant | |
KR20240060924A (en) | Cosmetic composition providing uv protection, whitening, antibacterial function using natural materials | |
Nacht | Melanin, Nature’s Own Sunscreen Polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA MX US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2231275 Country of ref document: CA Kind code of ref document: A Ref document number: 2231275 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1998/001733 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997935379 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09029592 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1997935379 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997935379 Country of ref document: EP |